Search Results - "Moody, Jeanne"
-
1
Design and synthesis of new tricyclic indoles as potent modulators of the S1P1 receptor
Published in Bioorganic & medicinal chemistry letters (01-02-2015)“…[Display omitted] Modulators of S1P1 have proven utility for the treatment of autoimmune disease and efforts to identify new agents with improved safety and…”
Get full text
Journal Article -
2
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate‑1 Receptor
Published in ACS medicinal chemistry letters (11-12-2014)“…APD334 was discovered as part of our internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next…”
Get full text
Journal Article -
3
Design and synthesis of new tricyclic indoles as potent modulators of the S1P sub(1) receptor
Published in Bioorganic & medicinal chemistry letters (01-02-2015)“…Modulators of S1P sub(1) have proven utility for the treatment of autoimmune disease and efforts to identify new agents with improved safety and…”
Get full text
Journal Article -
4
(7‑Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2‑a]indol-1-yl)acetic Acids as S1P1 Functional Antagonists
Published in ACS medicinal chemistry letters (11-12-2014)“…S1P1 is a validated target for treatment of autoimmune disease, and functional antagonists with superior safety and pharmacokinetic properties are being sought…”
Get full text
Journal Article -
5
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P₁ agonists
Published in Bioorganic & medicinal chemistry letters (01-10-2011)“…S1P₁ receptor driven lymphopenia has proven utility in the treatment of an array of autoimmune disease states. As a part of our efforts to develop potent and…”
Get full text
Journal Article -
6
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P 1 agonists
Published in Bioorganic & medicinal chemistry letters (01-10-2011)“…S1P 1 receptor driven lymphopenia has proven utility in the treatment of an array of autoimmune disease states. As a part of our efforts to develop potent and…”
Get full text
Journal Article -
7
Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P sub(1 agonists)
Published in Bioorganic & medicinal chemistry letters (01-10-2011)“…S1P sub(1) receptor driven lymphopenia has proven utility in the treatment of an array of autoimmune disease states. As a part of our efforts to develop potent…”
Get full text
Journal Article -
8
Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease
Published in Bioorganic & medicinal chemistry letters (01-07-2012)“…Two series of fused tricyclic indoles were identified as potent and selective S1P1 agonists. In vivo these agonists produced a significant reduction in…”
Get full text
Journal Article -
9
(7-Benzyloxy-2,3-dihydro- 1H -pyrrolo[1,2- a ]indol-1-yl)acetic Acids as S1P 1 Functional Antagonists
Published in ACS medicinal chemistry letters (11-12-2014)Get full text
Journal Article